Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share


Therapeutic Areas: Oncology | Otolaryngology (Ear, Nose, Throat) | Family Medicine

Head and Neck Cancer Clinical Trials


A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Alabama Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Arizona

Scottsdale : 21st Century Oncology

Squamous Cell Carcinoma

View More »

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Arkansas

Fayetteville : Highlands Oncology Group SC

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

California

San Diego : UC San Diego New

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

La Jolla : Moores UC San Diego Cancer Center

A clinical trial to evaluate treatments using GL-ONC1 for patients with Cancer of Head and Neck

Los Angeles : University of Southern California Updated

A clinical study for patients with Cystic Fibrosis

Los Angeles : UCLA Hematology-Oncology Clinic

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Pismo Beach : PCR Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

San Francisco : University of California, San Francisco

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

Santa Monica : Sarcoma Oncology Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Stanford : Stanford University

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Colorado

Greenwood Village : Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Connecticut

New Haven :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Norwalk : Whittingham Cancer Center Norwalk Hospital

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

District of Columbia

Washington : Georgetown Lombardi Comprehensive Cancer Center

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Fort Myers : Florida Cancer Specialists Florida Cancer Specialists (31

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Hollywood : Memorial Cancer Institute Memorial Healthcare System

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Jacksonville : Cancer Specialists of North Florida Cancer Specialists (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Tampa :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

View More »

Titusville : Space Coast Medical Associates Space Coast Cancer Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Georgia

Savannah : Memorial University Medical Center

ECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

Savannah : Memorial University Medical Center

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.

Savannah : Memorial University Medical Center

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Savannah : Memorial University Medical Center

RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

View More »

Athens : University Cancer & Blood Center, LLC

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Marietta : NorthWest Georgia Oncology Centers NW Georgia Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Newnan : Southeastern Regional Medical Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Illinois

View More »

Chicago : The University of Chicago Medical Center

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

Chicago : Lurie Children's Hospital of Chicago Developmental Therapeutics

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Chicago : The University of Chicago Medical Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : Northwestern University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : University of Illinois-Chicago

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chicago : The University of Chicago

A clinical trial to evaluate treatments using MGA271 for patients

Chicago : University Of Chicago

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Harvey : Ingalls Cancer Research Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Peoria : Illinois Cancer Care

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Peoria : Illinois Cancer Care IL Cancer Specialists

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Schaumburg : Cancer Treatment Centers of America Seattle Cancer Wellness

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Indiana

Indianapolis : Indiana University Indiana Univ. - Purdue Univ.

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Lafayette : Horizon Oncology Center Horizon Oncology Ctr.

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Iowa

Iowa City : Holden Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Head and Neck Neoplasms

Kansas

Fairway : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Kansas City : University of Kansas

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Louisiana

Shreveport : Louisianna State University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Maryland

Baltimore : St. Agnes Hospital St. Agnes Hospital (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Baltimore :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Massachusetts

Boston : Massachusetts General Hospital

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Boston : Dana-Farber Cancer Institute

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Boston : Tufts Medical Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital

A Phase 1/1b clinical study for patients with Advanced Cancer

Boston : Dana-Farber Cancer Institute

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Boston :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Boston :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Michigan

Detroit : Henry Ford Health System

Squamous Cell Carcinoma

View More »

Ann Arbor : University of Michigan Int. Medicine Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Ann Arbor : University of Michigan

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Grand Rapids : Cancer and Hematology Centers of West Michigan Dept. of Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Minnesota

Minneapolis : University of Minnesota - Cystic Fibrosis Center Updated

A clinical study for patients with Cystic Fibrosis

Minneapolis : Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Minneapolis : University of Minnesota

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Mississippi

View More »

Jackson : University of Mississippi

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Missouri

St. Louis : Washington University Center for Advanced Medicine

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

St. Louis : Washington University, Alvin J. Siteman Cancer Center New

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

St. Louis : Washington University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

St. Louis : Washington University Center for Advanced Medicine

A Phase 1/1b clinical study for patients with Advanced Cancer

Montana

Billings : Billings Clinic Onc Dept

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nebraska

Lincoln : Southeast Nebraska Oncology Cancer Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nevada

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Las Vegas :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Reno : VA Sierra Nevada Health Care System

A Phase 2 clinical study for patients with Head and Neck Neoplasms

New Jersey

View More »

Hackensack : Hackensack University Medical Center Dept of Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

New York

Bronx : Biomedical Research Alliance of New York

Head and Neck Cancer, Melanoma, and Other Superficial Cancers

New York : Columbia University Medical Center

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More »

Albany :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

New York : Icahn School of Medicine at Mount Sinai

A clinical research study of ADXS11-001 (ADXS-HPV) for the treatment of Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck or Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

New York : Memorial Sloan Kettering Cancer Center

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York : Columbia University

A Phase 1/1b clinical study for patients with Advanced Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

North Carolina

Durham : Duke University Medical Center

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Greenville : 21st Century Oncology

Squamous Cell Carcinoma

View More »

Chapel Hill : University of North Carolina at Chapel Hill

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

Chapel Hill : University of North Carolina

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Chapel Hill : The University of North Carolina at Chapel Hill

A Phase 2 clinical study for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Chapel Hill : University of North Carolina

A Phase 2 clinical study for patients with Head and Neck Neoplasms

Durham : Duke University Medical Center Seeley G. Mudd Bldg.

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Huntersville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Ohio

Cincinnati : Oncology Hematology Care, Inc. Oncology Hematology Care (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Cleveland : Cleveland Clinic Cleveland Clinic (19)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Columbus : Ohio State University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Oregon

Portland : Oregon Health & Science University OHSU Knight Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Portland : Providence Oncology & Hematology Care Eastside

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Portland : Portland VA Medical Center

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Salem : Salem Health

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Pennsylvania

Philadelphia : Fox Chase Cancer Center New

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Pittsburgh : University of Pittsburgh Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Rhode Island

Providence : Rhode Island Hospital Rhode Island Hosp. (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

South Carolina

Charleston : Medical University of South Carolina Hollings Cancer Center

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Spartanburg : Gibbs Cancer Center & Research Institute Spartanburg Reg. Healthcare

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tennessee

Nashville : Sarah Cannon Research Institute

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More »

Chattanooga : Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Memphis : The West Clinic

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nashville : Vanderbilt University

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

Nashville : Sarah Cannon Research Institute

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville : Sarah Cannon Research Institute Tennessee Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nashville : Vanderbilt University

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Sarah Cannon Research Institute

A Phase 1/1b clinical study for patients with Advanced Cancer

Nashville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Nashville :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Texas

Houston : University of Texas, MD Anderson Cancer Center New

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Austin : Austin Cancer Centers Austin Cancer Center (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Dallas : Texas Oncology Texas Oncology - Sammons

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Dallas : Texas Oncology SC

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Fort Worth : The Center for Cancer and Blood Disorders

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Galveston : The University of Texas Medical Branch at Galveston

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Houston : Oncology Consultants Oncology Group

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Cetuximab, IMC-A12 and Surgical tumor resection for patients with Head and Neck Squamous Cell Carcinoma

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : University of Texas MD Anderson

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

San Antonio : South Texas Accelerated Research Therapeutics

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Tyler : Tyler Cancer Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Utah

Salt Lake City : Huntsman Cancer Institute

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More »

Murray : Intermountain Medical Center Intermountain Healthcare

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Salt Lake City : University of Utah Updated

A clinical study for patients with Cystic Fibrosis

Virginia

Fairfax : Virginia Cancer Specialists, PC Virginia Cancer Specialists

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Norfolk :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Washington

Everett : Providence Regional Cancer Partnership Providence Reg. Cancer (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Seattle : University of Washington

A clinical research study of Cetuximab, Nab-paclitaxel and Carboplatin for the treatment of Head and Neck Cancer

Spokane : Evergreen Hematology & Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tacoma : Northwest Medical Specialties Hematology/Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Wenatchee : Wenatchee Valley Medical Center Wenatchee Valley

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

View More »

Yakima : Yakima Valley Memorial Hospital North Star Lodge Cancer Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

E1311- A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence

Morgantown : West Virginia University - Clinical Trials Research Unit

ECOG1305 - A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

Morgantown : West Virginia University - Clinical Trials Research Unit

RTOG-0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Morgantown : West Virginia University - Clinical Trials Research Unit

RTOG1216 - Randomized Phase II/III Trial of Surgery and Postoperavtive Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Wisconsin

Milwaukee : Aurora Research Institute

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Milwaukee : Medical College of Wisconsin Cancer Ctr.-Froedtert Hospital

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Austria

Innsbruck : Medical University of Innsbruck, Department for Internal Medicine I

Patients are needed to participate in a clinical research study of Lenalidomide and Cetuximab to evaluate Solid Tumors

Belgium

Bruxelles : Cliniques Universitaires St-Luc, Service d'oncologie médicale

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Jules Bordet Institute

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bosnia

Banja Luka : Clinical Center Banja Luka

Squamous Cell Carcinoma

Canada

Edmonton : Cross Cancer Institute New

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Vancouver : British Columbia Cancer Agency

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

China

Guangzhou : Cancer center, Sun Yat-sen University

A clinical trial seeking patients for a research study for the treatment of Head and Neck Squamous Carcinoma or Nasopharyngeal Carcinoma

Croatia

Osijek : CHC Osijek

Squamous Cell Carcinoma

Zagreb : KBC Sestre Milosrdnice

Squamous Cell Carcinoma

Zagreb : CH Dubrava

Squamous Cell Carcinoma

Zagreb : KBC Zagreb

Squamous Cell Carcinoma

France

Lyon :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Paris : Institut Curie

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Toulouse :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Villejuif :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Germany

Berlin :

Patients are needed to participate in a clinical research study evaluating MEHD7945A and cetuximab for the treatment of Head and Neck Cancer

Essen : Updated

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Germany : University of Heidelberg Medical Center

A clinical trial to evaluate treatments using Erbitux® and Fractionated Radiotherapy for patients with Head and Neck Cancer

Heidelberg : University of Heidelberg Medical Center

A clinical research study of ECA and Standard topical treatment of the institution, e.g. Lotio for the treatment of Pain

Würzburg : Updated

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Hungary

Budapest : Uzsoki Hospital

Squamous Cell Carcinoma

Israel

Haifa : Rambam Health Care Campus

Squamous Cell Carcinoma

Tikva : Rabin Medical Center

Squamous Cell Carcinoma

View More »

Tel Aviv : Sourasky Medical Center Updated

Patients are needed to participate in a clinical research study evaluating IZN-6N4 for the treatment of Oral Mucositis

Italy

Milano :

Patients are needed to participate in a clinical research study evaluating MEHD7945A and cetuximab for the treatment of Head and Neck Cancer

Japan

Chubu Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Chugoku Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Kanto Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Kinki Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

Tohoku Region :

Patients are needed to participate in a clinical research study evaluating Placebo, 2% Rebamipide liquid and 4% Rebamipide liquid for the treatment of Head and Neck Cancer

View More »

Tsu : Mie University Hospital

A clinical trial to evaluate treatments using TBI-1201, Cyclophosphamide and Fludarabine for patients with Solid Tumors

Korea, Republic of

Seoul : Seoul St.Mary's Hospital of the Catholic University of Korea

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer

Seoul : Updated

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Netherlands

Amsterdam : Netherlands Cancer Institute

A Phase 2 clinical study for patients with Head and Neck Cancer

Nijmegen : University Medical Center Nijmegen st Radboud

A Phase 2 clinical study for patients with Head and Neck Cancer

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Norway

Oslo : Oslo University Hospital Radiumhospitalet

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Poland

Portugal

Porto : Hospital CUF Porto

Patients are needed to participate in a clinical research study evaluating LUZ11 for the treatment of Head and Neck Cancer

Russia

Moscow : Blokhin Cancer Research Center

Squamous Cell Carcinoma

Serbia

Spain

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Switzerland

St. Gallen : Updated

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Taiwan

Changua : Changua Christian Hospital

Squamous Cell Carcinoma

Ukraine

United Kingdom

London : Guy's Hospital

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

London :

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Papworth Everard : Papworth Hospital NHS Trust

Patients are needed to participate in a clinical research study of Gefitinib to evaluate Lung Cancer or Head and Neck Cancer